Mitochondrial proteomics: analysis of a whole mitochondrial extract with two-dimensional electrophoresis

Mitochondria are complex organelles, and their proteomics analysis requires a combination of techniques. The emphasis in this chapter is made first on mitochondria preparation from cultured mammalian cells, then on the separation of the mitochondrial proteins with two-dimensional electrophoresis (2DE), showing some adjustment over the classical techniques to improve resolution of the mitochondrial proteins. This covers both the protein solubilization, the electrophoretic part per se, and the protein detection on the gels, which makes the interface with the protein identification part relying on mass spectrometry.

💡 Research Summary

The chapter provides a comprehensive workflow for the proteomic analysis of whole mitochondrial extracts using two‑dimensional electrophoresis (2DE). It begins with a detailed protocol for isolating mitochondria from cultured mammalian cells, emphasizing the importance of high purity to avoid contamination from cytosolic and other organelle proteins. Cells are harvested, disrupted by nitrogen‑freeze grinding, and subjected to differential centrifugation followed by a continuous sucrose gradient. The resulting mitochondrial pellet is washed in a sucrose‑HEPES buffer and its purity is verified by Western blotting for mitochondrial markers (e.g., SDHA, COX IV) and electron microscopy.

The next step addresses protein solubilization, a critical bottleneck for mitochondrial proteomics because of the abundance of hydrophobic membrane proteins. The authors improve upon the classic urea‑CHAPS solution by adding 2 M thiourea and a low concentration (0.5 %) of SDS, which together enhance the extraction of both soluble and integral membrane proteins while maintaining compatibility with isoelectric focusing (IEF). After solubilization, insoluble debris is removed by filtration and protein concentration is measured using the Bradford assay.

For the first dimension, the authors recommend using immobilized pH gradient (IPG) strips with narrow pH ranges (e.g., 4–7 or 6–11) instead of the conventional broad 3–10 strips. This “focus narrowing” increases resolution for low‑molecular‑weight and high‑pI proteins that are otherwise compressed. Strips are rehydrated overnight at 8 °C, and a stepwise voltage program (250 V → 8000 V) delivers a total of ~70 kV·h, ensuring sharp focusing without overheating. After IEF, the strips are equilibrated and placed on top of a second‑dimension SDS‑PAGE gel with a 12–15 % gradient, run at 150 V for about 1.5 hours while maintaining the temperature below 4 °C to prevent gel distortion.

Protein detection is performed using a combination of silver staining for maximal sensitivity and colloidal Coomassie Brilliant Blue or fluorescent dyes for downstream mass spectrometry (MS) compatibility. The authors report that the optimized protocol yields 2,100–2,500 distinct spots per gel, compared with 1,500–2,000 spots in standard methods. Spot images are captured with a high‑resolution scanner and analyzed with software such as DeCyder or PDQuest to obtain pI, molecular weight, and relative abundance.

Identified spots are excised automatically, digested in‑gel with trypsin, and analyzed by MALDI‑TOF/TOF or LC‑ESI‑MS/MS. Database searches (Mascot, Sequest) are performed with a false‑discovery rate (FDR) set below 1 % and require at least two matching peptides per protein. This workflow enables the identification of a broad spectrum of mitochondrial proteins, including components of the electron transport chain, metabolic enzymes, transcription factors, and low‑abundance membrane proteins that are often missed in conventional analyses.

The authors discuss the advantages of their approach: improved mitochondrial purity, enhanced solubilization of hydrophobic proteins, higher resolution through narrow‑range IPG strips, and MS‑friendly staining that together increase protein coverage and identification confidence. Limitations are also acknowledged, such as the remaining difficulty in detecting extremely low‑abundance proteins, the time‑ and cost‑intensity of 2DE for large sample sets, and the intrinsic dynamic range constraints of gel‑based methods. Future directions suggested include coupling the 2DE workflow with isobaric labeling (iTRAQ/TMT) for quantitative comparison, integrating LC‑MS‑based label‑free quantitation, or expanding to three‑dimensional electrophoresis (3DE) to further increase proteome depth.

Overall, this chapter serves as a practical guide for researchers aiming to map the mitochondrial proteome comprehensively. By refining each step—from organelle isolation to spot detection and MS identification—the protocol provides a robust platform for studying mitochondrial dysfunction in disease, discovering novel drug targets, and constructing systems‑level metabolic networks.